CVT-301 (Inbrija)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CVT-301 (Inbrija), covering 2017-07-27 to 2017-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes [Phase 2]